These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11515986

  • 1. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ, van Ouwerkerk BM, van der Meulen J, Zwinderman AH.
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF, Gerocarni B, Rosticci M, Borghi C.
    Clin Exp Hypertens; 2012 Jul; 34(2):113-7. PubMed ID: 21967031
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fixed-dose combination lercanidipine/enalapril.
    Hair PI, Scott LJ, Perry CM.
    Drugs; 2007 Jul; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC.
    Arzneimittelforschung; 2010 Jul; 60(3):124-30. PubMed ID: 20422943
    [Abstract] [Full Text] [Related]

  • 12. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
    Shigihara T, Sato A, Hayashi K, Saruta T.
    Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG, Pontremoli R.
    J Nephrol; 2011 May; 24(4):428-37. PubMed ID: 21279953
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C, Flati V, Rossini C, Rufo A, Porteri E, Di Gregorio J, Petroboni B, La Boria E, Donini C, Pasini E, Agabiti Rosei E, Rizzoni D.
    Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
    [Abstract] [Full Text] [Related]

  • 20. Lercanidipine: a review of its use in hypertension.
    McClellan KJ, Jarvis B.
    Drugs; 2000 Nov; 60(5):1123-40. PubMed ID: 11129125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.